Cited by 27

The DOI matches its Crossref record.

Chronic active hepatitis caused by benzarone

Babany, Gérard, Larrey, Dominique, Pessayre, Dominique, Degott, Claude, Rueff, Bernard, Benhamou, Jean-Pierre·1987·Journal of Hepatology

Abstract

We report a case of chronic active hepatitis caused by benzarone, a benzofuran derivative used in Europe for the treatment of peripheral venous disorders. Jaundice and serum alanine aminotransferase activity increased while drug administration was continued, but promptly decreased when it was eventually interrupted. Liver lesions were those of chronic active hepatitis. Anti-smooth muscle antibodies were present at a titer of 1:500 and disappeared 8 months after withdrawal of benzarone.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0168-8278(87)80039-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 26

  1. Deltour, 1965, Recherches dans la série des benzofurannes. X. Etude pharmacologique et toxicologique de l'éthyl-2-(hydroxy-4-benzoyl)-3-benzofuranne, Arch Int Pharmacodyn, 154, 94
  2. Felix, 1978, Über den Einfluss des Benzarons auf das Polidocanol- und Thiopental-Ödem am Hinterlauf der Katze, Arzneim-Forsch, 28, 2300
  3. Poucell, 1984, Amiodarone-associated phospholipidosis of the liver. Light, immunohistochemical, and electron microscopic studies, Gastroenterology, 86, 926, 10.1016/S0016-5085(24)05145-X · DOI
  4. Simon, 1984, Amiodarone hepatotoxicity simulating alcoholic liver disease, N Engl J Med, 311, 167, 10.1056/NEJM198407193110308 · DOI
  5. Pevny, 1984, Benzaron allergy, Contact Dermatitis, 11, 122, 10.1111/j.1600-0536.1984.tb00941.x · DOI
  6. Bonkowsky, 1978, Chronic hepatic inflammation and fibrosis due to low doses of paractamol, Lancet, i, 1016, 10.1016/S0140-6736(78)90740-7 · DOI
  7. Maddrey, 1975, Severe hepatitis from methyldopa, Gastroenterology, 68, 351, 10.1016/S0016-5085(75)80018-7 · DOI
  8. Seaman, 1974, Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus, Ann Intern Med, 80, 1, 10.7326/0003-4819-80-1-1 · DOI
  9. Pessayre, 1981, Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin, Digestion, 22, 66, 10.1159/000198597 · DOI
  10. Utili, 1977, Dantrolene-associated hepatic injury. Incidence and character, Gastroenterology, 72, 610, 10.1016/S0016-5085(77)80141-8 · DOI
  11. Thomas, 1974, Chronic aggressive hepatitis induced by halothane, Ann Intern Med, 81, 487, 10.7326/0003-4819-81-4-487 · DOI
  12. Black, 1975, Isoniazid-associated injury in 114 patients, Gastroenterology, 69, 289, 10.1016/S0016-5085(19)32568-5 · DOI
  13. Tobias, 1973, Hepatotoxicity of long term methotrexate therapy for psoriasis, Arch Intern Med, 132, 391, 10.1001/archinte.1973.03650090071013 · DOI
  14. Sharp, 1980, Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin, Ann Intern Med, 92, 14, 10.7326/0003-4819-92-1-14 · DOI
  15. Black, 1980, Nitrofurantoin-induced chronic active hepatitis, Ann Intern Med, 92, 62, 10.7326/0003-4819-92-1-62 · DOI
  16. Reynolds, 1971, Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin, N Engl J Med, 285, 813, 10.1056/NEJM197110072851501 · DOI
  17. Poupon, 1978, Hépatite chronique associée à la prise prolongée de papavérine, Gastroenterol Clin Biol, 2, 305
  18. Pessayre, 1979, Perhexiline maleate-induced cirrhosis, Gastroenterology, 76, 170, 10.1016/S0016-5085(79)80145-6 · DOI
  19. Benjamin, 1981, Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature, Hepatology, 1, 255, 10.1002/hep.1840010311 · DOI
  20. Fedotin, 1975, Liver disease caused by propylthiouracil, Arch Intern Med, 135, 319, 10.1001/archinte.1975.00330020123017 · DOI
  21. Tönder, 1974, Sulfonamide-induced chronic liver disease, Scand J Gastroenterol, 9, 93, 10.1080/00365521.1974.12096796 · DOI
  22. Zimmerman, 1984, Ticrynafen-associated hepatic injury: analysis of 340 cases, Hepatology, 4, 315, 10.1002/hep.1840040223 · DOI
  23. Babany, 1986, Chronic liver disease after low daily doses of amiodarone. Report of three cases, J Hepatol, 3, 228, 10.1016/S0168-8278(86)80031-9 · DOI
  24. Elving, 1986, Amiodarone hepatotoxicity, Neth J Med, 29, 303
  25. Coste, 1986, Hépatite chronique associée à la prise d'amiodarone: une nouvelle observation, Gastroenterol Clin Biol, 10, 689
  26. De Korwin, 1986, Hépatite aiguë imputée à l'amiodarone, Gastroenterol Clin Biol, 10, 688

Cited by

Sorted by citations

Metadata

Authors
Babany, G., Larrey, D., Pessayre, D., Degott, C., Rueff, B., & Benhamou, J.-P.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
1987-01
Volume
5
Issue
3
Pages
332-335
ISSN
0168-8278
Cited by
27
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review